These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26509849

  • 1. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
    Mueller JJ, Holzapfel M, Han CH, Santos K, Gunderson C, Moore K, Erickson B, Leath CA, Diaz E, Walsh C, Wethington SL, Dejbakhsh SZ, Barakat RR, Gardner GJ, Hyman DM, Soslow RA, Leitao MM.
    Int J Gynecol Cancer; 2016 Jan; 26(1):120-4. PubMed ID: 26509849
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA.
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H, Moslemi-Kebria M, Levinson KL, Gojayev A, Lockhart D, Ali-Fehmi R, Munkarah AR.
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [Abstract] [Full Text] [Related]

  • 4. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
    Ulker V, Kuru O, Numanoglu C, Akbayır O, Polat I, Uhri M.
    Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
    [Abstract] [Full Text] [Related]

  • 5. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
    Takei Y, Takahashi S, Machida S, Taneichi A, Yoshiba T, Takahashi Y, Yoshida C, Saga Y, Matsubara S, Fujiwara H.
    Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.
    Yamazaki H, Todo Y, Shimada C, Takeshita S, Minobe S, Okamoto K, Yamashiro K, Kato H.
    J Gynecol Oncol; 2018 Mar; 29(2):e19. PubMed ID: 29400012
    [Abstract] [Full Text] [Related]

  • 7. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.
    Minig L, Heitz F, Cibula D, Bakkum-Gamez JN, Germanova A, Dowdy SC, Kalogera E, Zapardiel I, Lindemann K, Harter P, Scambia G, Petrillo M, Zorrero C, Zanagnolo V, Rebollo JMC, du Bois A, Fotopoulou C.
    Ann Surg Oncol; 2017 Sep; 24(9):2720-2726. PubMed ID: 28608122
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.
    Desteli GA, Gultekin M, Usubutun A, Yuce K, Ayhan A.
    World J Surg Oncol; 2010 Nov 30; 8():106. PubMed ID: 21114870
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N, Yamada H, Oikawa M, Okuyama K, Fujino T, Sagawa T, Fujimoto S.
    Gynecol Oncol; 2000 Nov 30; 79(2):251-5. PubMed ID: 11063653
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.
    Zhu C, Zhu J, Qian L, Liu H, Shen Z, Wu D, Zhao W, Xiao W, Zhou Y.
    BMC Cancer; 2021 Mar 25; 21(1):322. PubMed ID: 33766002
    [Abstract] [Full Text] [Related]

  • 12. Lymph node metastasis in grossly apparent early-stage epithelial ovarian cancer: A retrospective clinical study at a tertiary institute.
    Zhu M, Li J, Lu L, Duan J, Jiang W.
    J Cancer Res Ther; 2024 Aug 01; 20(4):1300-1305. PubMed ID: 39206992
    [Abstract] [Full Text] [Related]

  • 13. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H, Takeda M, Fujimoto T, Todo Y, Ebina Y, Watari H, Yamamoto R, Minakami H, Sakuragi N.
    Gynecol Oncol; 2004 Jul 01; 94(1):161-6. PubMed ID: 15262135
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A, Toptas T, Dogan S, Simsek T, Pestereli E.
    Int J Gynecol Cancer; 2015 May 01; 25(4):657-64. PubMed ID: 25647255
    [Abstract] [Full Text] [Related]

  • 15. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
    Svolgaard O, Lidegaard O, Nielsen ML, Nedergaard L, Mosgaard BJ, Lidang M, Mogensen O, Kock K, Blaakaer J, Staehr E, Andersen ES, Grove A, Høgdall C.
    Acta Obstet Gynecol Scand; 2014 Mar 01; 93(3):256-60. PubMed ID: 24447203
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
    Ataseven B, Grimm C, Harter P, Prader S, Traut A, Heitz F, du Bois A.
    Gynecol Oncol; 2014 Dec 01; 135(3):435-40. PubMed ID: 25312398
    [Abstract] [Full Text] [Related]

  • 17. Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
    Signorelli M, Guerra L, Pirovano C, Crivellaro C, Fruscio R, Buda A, Cuzzucrea M, Elisei F, Ceppi L, Messa C.
    Gynecol Oncol; 2013 Nov 01; 131(2):395-9. PubMed ID: 23988414
    [Abstract] [Full Text] [Related]

  • 18. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K, Umayahara K, Abe A, Usami T, Yamamoto A, Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Takeshima N.
    Int J Gynecol Cancer; 2015 Jan 01; 25(1):81-6. PubMed ID: 25347094
    [Abstract] [Full Text] [Related]

  • 19. Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review.
    Lago V, Minig L, Fotopoulou C.
    Int J Gynecol Cancer; 2016 Oct 01; 26(8):1407-14. PubMed ID: 27465900
    [Abstract] [Full Text] [Related]

  • 20. The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.
    Kucukgoz Gulec U, Paydas S, Guzel AB, Vardar MA, Khatib G, Gumurdulu D.
    Arch Gynecol Obstet; 2015 Oct 01; 292(4):923-9. PubMed ID: 25855053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.